We show you our most important and recent visitors news details EU medicines regulator approves new COVID-19 vaccine production sites in the following article
Hind Al Soulia - Riyadh - BRUSSELS — The European Union's medicines agency has approved three new production sites for coronavirus vaccines, in a bid to boost the continent's supply of shots after weeks of delays and shortages.
The EMA said it had approved facilities in the Netherlands, Germany, and Switzerland to churn out vaccines made respectively by AstraZeneca, Pfizer, and Moderna.
The agency also said it was granting more flexible storage conditions to the Pfizer vaccine, which had so far required ultra-low temperatures of around minus 70 degrees Celsius. The doses can now be transported and stored in standard freezers at temperatures between minus 25 to minus 15 degrees Celsius for a one-off period of two weeks.
The changes come as the EU has been plagued by delivery delays, and struggling to ramp up its vaccination campaign.
The newly approved site in the Dutch city of Leiden, which makes the active substance for AstraZeneca’s vaccine, has been at the heart of a major supply dispute between the EU and the UK.
This week, Brussels threatened to ban shipments of the jabs to Britain to ensure that they go to Europeans first.
On Thursday night, EU leaders gave their cautious support to export controls and pledged to ramp up production on European soil to counter a fresh surge in COVID-19 cases. — Euronews
These were the details of the news EU medicines regulator approves new COVID-19 vaccine production sites for this day. We hope that we have succeeded by giving you the full details and information. To follow all our news, you can subscribe to the alerts system or to one of our different systems to provide you with all that is new.
It is also worth noting that the original news has been published and is available at Saudi Gazette and the editorial team at AlKhaleej Today has confirmed it and it has been modified, and it may have been completely transferred or quoted from it and you can read and follow this news from its main source.